WARF currently is working with approximately 60 active startups whose business markets include biotech, clean technology, high-tech, medical devices, research tools, stem cells and therapeutics. WARF currently holds equity in more than 30 of these companies. Some of WARF's startup companies have achieved IPO status as publicly traded companies and have been acquired by large, well-established companies, such as Roche and Hologic.
ECQ Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held
